Conference News

ADA 2022 Best Albuminuria Drug for Diabetes Varies by Patient Results from 63 people with diabetes and albuminuria in the ROTATE study belie the idea that renin-angiotensin system inhibitors always work best. For many patients, other drug classes work better.
News, June 22, 2022
ENDO 2022 Bone Density Loss in Lean Male Runners Parallels Similar Issue in Women Male runners with lean body mass, like female runners, risk bone density loss that may be hormonally related.
News, June 22, 2022
Visa Delays a Worry for International AIDS Conference in Montreal Cochair predicts "a catastrophe for the spirit of the conference, for the image of Canada, and the federal government,"
News, June 21, 2022
CMSC 2022 COVID Vaccination in DMT-Treated MS Patients: New Data COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies.
News, June 21, 2022
EULAR 2022 Osteoporosis Risk Rises With Air Pollution Levels Chronic exposure to particulate matter 2.5 micrometers or larger in size at concentrations above 25 micrograms per cubic meter raised the likelihood of osteoporosis by 18%-22% in a 7-year longitudinal study.
News, June 21, 2022
ENDO 2022 Empagliflozin Eyed for Outpatient Chronic Hyponatremia The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis.
News, June 21, 2022
AUGS 2022 Remote Workouts May Ease Urinary Incontinence In a pilot study, mostly premenopausal women who completed 8 weeks of video-guided pelvic floor exercises reported less leakage and improved symptoms.
News, June 21, 2022
EPA 2022 Advance Directives for Psych Care Reduce Compulsory Admissions Providing peer or community health worker support to help psychiatric patients complete advance directives is associated with a 42% reduction in compulsory hospital admissions, new research shows.
News, June 21, 2022
CMSC 2022 No Clear Answers From MS Drug Discontinuation Trial The first randomized trial to examine if older adults with multiple sclerosis can discontinue disease-modifying therapy after years of being relapse-free failed to deliver a definitive conclusion.
News, June 20, 2022
ENDO 2022 Could a Type 2 Diabetes Drug Tackle Kidney Stones? A pooled data analysis of trials of the SGLT2 inhibitor empagliflozin in type 2 diabetes suggests it may lower the risk of kidney stones. However, this is early research.
News, June 20, 2022
ENDO 2022 COVID-19 Pandemic Stress Affected Ovulation, Not Menstruation The 'experiment of nature' that coincided with the COVID-19 pandemic lockdown produced several findings that call into question commonly held beliefs about women's reproductive cycles.
News, June 17, 2022
EHA 2022 Zanubrutinib-Obinutuzumab Doubles PFS in Follicular Lymphoma Over the 12-month follow-up, significantly more patients who received the combination demonstrated a durable response compared with those who received obinutuzumab alone.
News, June 17, 2022
AHS 2022 Migraine-Related Stigma Common, Underappreciated Almost a third of patients with migraine have experienced some form of stigma in new findings that researchers say should prompt efforts to address this common and "stubborn" social problem.
News, June 17, 2022
ENDO 2022 Two Distinct Subtypes of PCOS Identified in Adolescents Different hormonal and cardiometabolic profiles found for girls with and without obesity, representing distinct 'metabolic' and 'reproductive' PCOS phenotypes.
News, June 17, 2022
ASCO 2022 Moral Distress in Oncology Practice Needs Tackling Head-on Moral distress from being unable to provide appropriate care or being forced into making questionable decisions is common in oncology, and it needs to be addressed.
News, June 17, 2022
APA 2022 Asian American Teens at Highest Risk for Suicidal Thoughts In a 2019 national survey of more than 13,000 high school students, 24% of Asian Americans reported thinking about or planning suicide.
News, June 17, 2022
APA 2022 Lower-Dose Antipsychotics Benefit Patients with Schizophrenia Patients with refractory schizophrenia in long-term forensic facilities show significant stabilization after reduced doses of long-acting injectable antipsychotics, new research suggests.
News, June 17, 2022
SLEEP 2022 Findings Raise Questions About Migraine, Risk for OSA Results from one of the largest case-based studies suggest patients with migraine and sleep-disordered breathing may not be at higher risk for obstructive sleep apnea — but more research is needed.
News, June 17, 2022
EHA 2022 New CAR-T Therapy Elicits Strong Response in Multiple Myeloma In a small study, one infusion of the investigational CAR T-cell therapy led to a complete response in most patients with no CAR-T-related neurotoxicity.
News, June 16, 2022
SLEEP 2022 Long-term Erratic Sleep May Predict Later-Life Cognitive Problems Inconsistent sleep patterns over the years, along with a patient's age and history of depression, may be harbingers of cognitive impairment later in life, new research suggests.
News, June 16, 2022

No Results